Changes


Philips Respironics Recall 2021

708 bytes added, 23:01, 14 July 2021
Impacted Devices
As a result of extensive ongoing analysis following this announcement, on June 14, 2021, the company issued a recall notification (U.S. only) / field safety notice (Outside of U.S.) for specific affected devices.
===Health Issues===
As reported by Philips Respironics
 
These issues (degrading foam and/or off-gassing) can result in
* serious injury which can be life-threatening,
* cause permanent impairment,
* and/or require medical intervention to preclude permanent impairment.
To date, Philips Respironics has
received several complaints regarding the presence of black debris/particles within the airpath circuit
(extending from the device outlet, humidifier, tubing, and mask).
 
Philips also has received reports of
headache,
upper airway irritation,
cough,
chest pressure and
sinus infection.
 
The potential risks of particulate exposure include:
* Irritation (skin, eye, and respiratory tract),
* inflammatory response,
* headache,
* asthma,
* adverse effects to other organs (e.g. kidneys and liver) and
* toxic carcinogenic affects.
 
The potential risks of chemical exposure due to off-gassing include:
* headache/dizziness,
* irritation (eyes, nose, respiratory tract, skin),
* hypersensitivity,
* nausea/vomiting,
* toxic and carcinogenic effects.
 
There have been no reports of death as a result of these issues.
===Impacted Devices===
All Devices manufactured before 26 April 2021,All serial numbersContinuous Ventilator, Minimum Ventilatory Support, Facility Use E30 (Emergency Use Authorization)Continuous Ventilator, Non-life Supporting DreamStation ASVDreamStation ST, AVAPSSystemOne ASV4C-Series ASVC-Series S/T and AVAPSOmniLab Advanced+Noncontinuous Ventilator SystemOne (Q-Series)DreamStationDreamStation GoDorma 400Dorma 500REMstar SE Auto
{| class="wikitable"
|-
131
edits



Donate to Apnea Board